Hepatitis A Virus

New Tests Beneficial in Assessing Response to Vaccine

Published in Hepatitis Weekly, April 10th, 1995

Researchers from German described a newly developed test to detect antibody to hepatitis A virus (anti-HAV), which should be of use in assessing the immunoresponse to the hepatitis A vaccine.

G. Hess and colleagues, Boehringer Mannheim GmbH, Mannheim, Germany, stated that the test has high sensitivity and the possibility to quantitate, using anti-HAV standards with known anti-HAV content ("Analysis of Immunoassays to Detect Antibodies to Hepatitis a Virus (Anti-HAV) and Anti-HAV Immunoglobulin M," Journal of Virological Methods, 1995;51:221-228).

"This enables this new anti-HAV test to recognize an early anti-HAV response in vaccinated individuals...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1995-04-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry